Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $118.1M | $151.5M | $162.7M | $181.7M | $147.7M | $231.3M | $252.4M | $212.4M |
| Cost of revenue | $49.9M | $65.4M | $82.3M | $83.5M | $71.9M | $98.2M | $112.6M | $170.9M |
| Gross profit | $68.1M | $86.1M | $80.4M | $98.2M | $75.8M | $133.1M | $139.8M | $41.5M |
| Gross margin | 57.7% | 56.8% | 49.4% | 54.0% | 51.3% | 57.6% | 55.4% | 19.5% |
| R&D | $11.2M | $12.9M | $14.4M | $15.1M | $14.3M | $21.6M | $25.2M | $21.4M |
| Operating income | $2.4M | $11.1M | −$13.4M | −$12.1M | −$22.8M | −$1.3M | −$38.2M | −$156.2M |
| EBITDA | $3.4M | $8.1M | −$12.2M | −$10.5M | −$16.9M | $58.0K | −$65.2M | −$140.9M |
| Net income | $2.6M | $30.0M | −$30.8M | −$12.3M | −$23.9M | $2.1M | −$82.3M | −$162.8M |
| Net margin | 2.2% | 19.8% | -18.9% | -6.8% | -16.2% | 0.9% | -32.6% | -76.7% |
| EPS (diluted) | 0.19 | 2.04 | -2.23 | -0.88 | -1.43 | 0.11 | -4.39 | -8.19 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $161M | $-1.94 | $-1.94–$-1.94 | 1 |
| 2027 | $215M | $-2.40 | $-2.40–$-2.40 | 1 |
| 2028 | $249M | $-1.37 | $-1.37–$-1.37 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds CUTR.
No tracked institution reports a position in CUTR as of their last filing.
No one on the platform has traded CUTR yet.
| $12M |
| — |
| MTPMidatech Pharma plc | $0.29 | -18.50% | $2M | — |
| NAYANAYA Biosciences, Inc. | $2.20 | +8.37% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 3.4× historical median P/S.
Fair value ≈ $40.10 · price $0.10 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$CUTR I thought this was Cutera laser. But it's a coin?
View on StockTwits ↗$CUTR Im glad I didnt get involved with this scam as well right $AVCTQ
View on StockTwits ↗$CUTR I had some shares on Revolut, but now its gone.. what happened to that? Will I still have that if the company ever gets relisted?
View on StockTwits ↗$CUTR Cutera Will Operate as a Private Co, Backed by a Consortium of Investment Firms >CUTR Dow Jones · May 1 14:23 1min Cutera(Delisted) (CUTRQ.US) 0.008 +0.00% Cutera Will Operate as a Private Co, Backed by a Consortium of Investment Firms >CUTR Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy.
View on StockTwits ↗$CUTR BIG Moves coming! https://www.moomoo.com/t/news/post/52458429/byryFZJfib
View on StockTwits ↗$CUTR I can’t trade/sell this on Robinhood. Anyone knows how to sell my position on Robinhood to claim loss?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.